Handbook of Clinical medicine

and bleeding, eg haemoptysis, haematuria. Bone pain from metastases can be reduced or eliminated in 60% of cases. Early reactions Occur ~2 weeks into treatment, peak ~2–4 weeks after treatment. • Tiredness: ~80%. Improves ~4 weeks after treatment completed but chronic in ~30%. Advise patients to stay as active as possible. • Skin reactions: Include erythema, dry desquamation, moist desquamation, and ulceration. Aqueous cream can be used on unbroken areas. • Mucositis: All patients receiving head and neck treatment should have a dental check-up before therapy. Avoid smoking. Antiseptic mouthwashes may help. Aspi- rin gargle and other soluble analgesics can be tried. Treat oral thrush with fl ucona- zole 50mg/24h PO, nystatin may exacerbate nausea. • Nausea and vomiting: Occur when stomach, liver, or brain treated. Try metoclo- pramide 10mg/8h PO (dopamine antagonist), domperidone 10mg/8h PO (blocks the central chemoreceptor trigger zone), or ondansetron 4–8mg/8h PO/IV (serotonin 5HT3 antagonist) (see p251). • Diarrhoea: Usually after abdominal or pelvic treatments. Maintain good hydration. Avoid high-fi bre agents. Try loperamide 2mg PO after loose stools (max 16mg/24h). • Dysphagia: Following thoracic treatments. Speech and language input, nutrition. • Cystitis: After pelvic treatments. Drink plenty of fl uid. Late reactions Months-years after treatment.
